Alan F. Hofmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan F. Hofmann has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Lee R Hagey
Division of Gastroenterology Department of Medicine USA
2 shared publications- Lee R. Hagey
Department of Medicine, University of California at San Diego, San Diego, CA, USA
2 shared publications - Matthew D. Krasowski
Department of Pathology, University of Iowa Hospitals and Clinics , Iowa City, IA
2 shared publications Christine A Packard
Department of Chemistry San Diego State University San Diego CA USA
1 shared publicationChristine Gruy-Kapral
1 shared publicationDale A Chatfield
Department of Chemistry San Diego State University San Diego CA USA
1 shared publication
Latest Publications
- 1 March 2010
- Published by University of Chicago Press in Physiological and Biochemical Zoology
- Vol. 83 (2) , 308-321
Diversity of Bile Salts in Fish and Amphibians: Evolution of a Complex Biochemical Pathway
Bile salts are the major end metabolites of cholesterol and are also important in lipid and protein digestion, as well as shaping of the gut microflora. Previous studies had demonstrated v...
- 1 March 2010
- Published by University of Chicago Press in Physiological and Biochemical Zoology
- Vol. 83 (2) , 308-321
Diversity of Bile Salts in Fish and Amphibians: Evolution of a Complex Biochemical Pathway
Bile salts are the major end metabolites of cholesterol and are also important in lipid and protein digestion, as well as shaping of the gut microflora. Previous studies had demonstrated v...
- Open Access
- 1 January 2010
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 10 (1) , 133
Evolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites
Bile salts are the major end-metabolites of cholesterol and are also important in lipid and protein digestion and in influencing the intestinal microflora. We greatly extend prior surveys of bile salt diversity in both reptiles and mammals, including analysis of 8,000 year old human coprolites and coprolites from the extinct Shasta ground sloth (Nothrotherium shastense).
- 1 January 2010
- Published by Springer Nature in BMC Ecology and Evolution
- Vol. 10 (1) , 133
Open AccessEvolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites
Bile salts are the major end-metabolites of cholesterol and are also important in lipid and protein digestion and in influencing the intestinal microflora. We greatly extend prior surveys of bile salt diversity in both reptiles and mammals, including analysis of 8,000 year old human coprolites and coprolites from the extinct Shasta ground sloth (Nothrotherium shastense).
- 1 November 2008
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (5) , 598-606
Altered Bile Acid Metabolism in Childhood Functional Constipation: Inactivation of Secretory Bile Acids by Sulfation in a Subset of Patients
Objective: An elevated concentration in the colon of the primary bile acid chenodeoxycholic acid (CDCA) or the secondary bile acid deoxycholic acid (DCA) is known to induce water secretion, causing diarrhea. We hypothesized that of the many fecal bile acids, only CDCA and DCA function as endogenous laxatives; therefore, a decrease in their proportion may be a cause of childhood functional constipation. To test this possibility, fecal bile acid composition was determined in children with functional constipation and in nonconstipated control children.Patients and Methods: Fecal samples were obtained from 207 children, 103 with functional constipation and 104 with normal bowel habits. Bile acid classes were determined by use of electrospray ionization—single ion monitoring—mass spectrometry (ESI‐SIM‐MS), and individual bile acids were measured by gas chromatography (GC)‐MS (GC‐MS). The structure of individual sulfated bile acids was obtained by use of liquid chromatography (LC)‐MS (LC‐MS).Results: By ESI‐SIM‐MS, the proportions of DCA did not differ in constipated children (n = 73) from that in control children (n = 92), but monosulfated dihydroxy bile acids were greater (P < 0.05). The difference was attributable to 6 patients in the constipated group whose major fecal bile acid by LC‐MS was the 3‐sulfate of CDCA. Sulfation of CDCA is known to abolish its secretory activity. By GC‐MS, the bile acid profile was identical in the 2 groups.Conclusions: In most children with functional constipation, the fecal bile acid profile seems to be normal. There is a small subset of children, however, whose dominant fecal bile acid is the 3‐sulfate of CDCA, indicating a novel disturbance in bile acid metabolism. Such sulfation abolishes the secretory activity of CDCA and may contribute to constipation.
- 1 November 2008
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 47 (5) , 598-606
Altered Bile Acid Metabolism in Childhood Functional Constipation: Inactivation of Secretory Bile Acids by Sulfation in a Subset of Patients
Objective: An elevated concentration in the colon of the primary bile acid chenodeoxycholic acid (CDCA) or the secondary bile acid deoxycholic acid (DCA) is known to induce water secretion, causing diarrhea. We hypothesized that of the many fecal bile acids, only CDCA and DCA function as endogenous laxatives; therefore, a decrease in their proportion may be a cause of childhood functional constipation. To test this possibility, fecal bile acid composition was determined in children with functional constipation and in nonconstipated control children.Patients and Methods: Fecal samples were obtained from 207 children, 103 with functional constipation and 104 with normal bowel habits. Bile acid classes were determined by use of electrospray ionization—single ion monitoring—mass spectrometry (ESI‐SIM‐MS), and individual bile acids were measured by gas chromatography (GC)‐MS (GC‐MS). The structure of individual sulfated bile acids was obtained by use of liquid chromatography (LC)‐MS (LC‐MS).Results: By ESI‐SIM‐MS, the proportions of DCA did not differ in constipated children (n = 73) from that in control children (n = 92), but monosulfated dihydroxy bile acids were greater (P < 0.05). The difference was attributable to 6 patients in the constipated group whose major fecal bile acid by LC‐MS was the 3‐sulfate of CDCA. Sulfation of CDCA is known to abolish its secretory activity. By GC‐MS, the bile acid profile was identical in the 2 groups.Conclusions: In most children with functional constipation, the fecal bile acid profile seems to be normal. There is a small subset of children, however, whose dominant fecal bile acid is the 3‐sulfate of CDCA, indicating a novel disturbance in bile acid metabolism. Such sulfation abolishes the secretory activity of CDCA and may contribute to constipation.
- Open Access
- 1 January 2007
- Published by Elsevier in Annals of Hepatology
- Vol. 6 (1) , 15-27
Biliary secretion and excretion in health and disease: Current concepts
- 1 January 2007
- Published by Elsevier in Annals of Hepatology
- Vol. 6 (1) , 15-27
Open AccessBiliary secretion and excretion in health and disease: Current concepts
- 1 June 2004
- Published by Elsevier in Gastroenterology
- Vol. 126 (7) , 1890-1892
Douglas B. McGill, 1929–2004
- 1 June 2004
- Published by Elsevier in Gastroenterology
- Vol. 126 (7) , 1890-1892
Douglas B. McGill, 1929–2004
- 1 January 2004
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 36 (3-4) , 703-722
Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity
Lithocholic acid, a monohydroxy, secondary bile acid, is formed by bacterial 7-dehydroxylation of the primary bile acid chenodeoxycholic acid (CDCA) and of the secondary bile acid ursodeoxycholic acid (UDCA). Lithocholic acid and its precursor CDCA are toxic when fed to the rabbit, rhesus monkey, and baboon, but not when CDCA, as well as UDCA, is used for therapeutic purposes in man. Older studies showed that the species specific toxicity of lithocholic acid could be explained by efficient sulfation of lithocholic acid in man and in chimpanzee, but not in the rabbit, rhesus monkey, or baboon. Rodents detoxify lithocholic acid by hydroxylation, but this does not occur in species in which it is toxic. Recent studies suggest that lithocholic acid induces its own detoxification by activating nuclear receptors to promote transcription of genes encoding sulfotransferase. In addition, work with CaCo2 cells suggest that lithocholic acid may undergo sulfation in the enterocyte and be effluxed back into the intestinal lumen. The evolution of trihydroxy bile acids in vertebrates may have occurred to decrease the formation of lithocholic acid. Lithocholic acid is a rare example of a toxic endobiotic; a variety of mechanisms have evolved to solve the problem of efficient detoxification.
- 1 January 2004
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 36 (3-4) , 703-722
Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity
Lithocholic acid, a monohydroxy, secondary bile acid, is formed by bacterial 7-dehydroxylation of the primary bile acid chenodeoxycholic acid (CDCA) and of the secondary bile acid ursodeoxycholic acid (UDCA). Lithocholic acid and its precursor CDCA are toxic when fed to the rabbit, rhesus monkey, and baboon, but not when CDCA, as well as UDCA, is used for therapeutic purposes in man. Older studies showed that the species specific toxicity of lithocholic acid could be explained by efficient sulfation of lithocholic acid in man and in chimpanzee, but not in the rabbit, rhesus monkey, or baboon. Rodents detoxify lithocholic acid by hydroxylation, but this does not occur in species in which it is toxic. Recent studies suggest that lithocholic acid induces its own detoxification by activating nuclear receptors to promote transcription of genes encoding sulfotransferase. In addition, work with CaCo2 cells suggest that lithocholic acid may undergo sulfation in the enterocyte and be effluxed back into the intestinal lumen. The evolution of trihydroxy bile acids in vertebrates may have occurred to decrease the formation of lithocholic acid. Lithocholic acid is a rare example of a toxic endobiotic; a variety of mechanisms have evolved to solve the problem of efficient detoxification.
- Open Access
Rifampicin and treatment of cholestatic pruritus
- 1 April 2002
- Published by Wiley in Liver International
- Vol. 22 (s2) , 14-19
Cholestatic liver disease: pathophysiology and therapeutic options
Cholestasis results from defective canalicular secretion of bile or obstruction to bile flow distal to the canaliculus. In early primary biliary cirrhosis, bile secretion continues, because of the secretory pressure of bile or because some ductules are not obstructed. With complete cholestasis, a bile acid deficiency occurs in the small intestinal lumen leading to lipid maldigestion and fat‐soluble vitamin malabsorption. Bacterial proliferation, bacterial translocation to lymph nodes and endotoxemia may also occur leading to an acute phase reaction. Retention of bile acids in the hepatocyte leads to apoptosis. Accumulation of bile acids in the systemic circulation leads to pruritus, and may contribute to endothelial injury in the lungs and kidney. Early attempts to mimic hepatic excretory function by hemoperfusion over adsorbent columns were unsuccessful for a variety of reasons. Extracorporeal dialysis against albumin offers promise of a realistic albeit partial simulation of hepatic excretory function.
- 1 April 2002
- Published by Wiley in Liver International
- Vol. 22 (s2) , 14-19
Cholestatic liver disease: pathophysiology and therapeutic options
Cholestasis results from defective canalicular secretion of bile or obstruction to bile flow distal to the canaliculus. In early primary biliary cirrhosis, bile secretion continues, because of the secretory pressure of bile or because some ductules are not obstructed. With complete cholestasis, a bile acid deficiency occurs in the small intestinal lumen leading to lipid maldigestion and fat‐soluble vitamin malabsorption. Bacterial proliferation, bacterial translocation to lymph nodes and endotoxemia may also occur leading to an acute phase reaction. Retention of bile acids in the hepatocyte leads to apoptosis. Accumulation of bile acids in the systemic circulation leads to pruritus, and may contribute to endothelial injury in the lungs and kidney. Early attempts to mimic hepatic excretory function by hemoperfusion over adsorbent columns were unsuccessful for a variety of reasons. Extracorporeal dialysis against albumin offers promise of a realistic albeit partial simulation of hepatic excretory function.
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A375
Cholylsarcosine (CS) improves fat absorption in short bowel syndrome (SBS)
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A375
Cholylsarcosine (CS) improves fat absorption in short bowel syndrome (SBS)